De La Cruz Sodium Bicarbonate Antacid Powder
NDC Package 24286-1537-7
Package Information
De La Cruz Sodium Bicarbonate Antacid (sodium bicarbonate) powders is take ½ level teaspoon in ½ glass (4 fl. This formulation utilizes a powder delivery system. Marketed by Dlc Laboratories, Inc., this product is identified by NDC 24286-1537 and is authorized under FDA application M001.
Identification & Billing
- RxCUI: 1488624 - sodium bicarbonate 2.6 GM Powder for Oral Solution
- RxCUI: 1488624 - sodium bicarbonate 2600 MG Powder for Oral Solution
- RxCUI: 1488624 - NaHCO3 2600 MG Powder for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 24286 - Dlc Laboratories, Inc.
- 24286-1537 - De La Cruz Sodium Bicarbonate Antacid
- 24286-1537-7 - 113 g in 1 BOTTLE, PLASTIC
- 24286-1537 - De La Cruz Sodium Bicarbonate Antacid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (24286-1537). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 24286-1537-7 identifies a specific commercial package of 113 g in 1 bottle, plastic of De La Cruz Sodium Bicarbonate Antacid, a human over the counter drug labeled by Dlc Laboratories, Inc.. This powder is formulated for oral use and contains sodium bicarbonate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dlc Laboratories, Inc. on September 25, 2013. The current certification is valid through December 31, 2027.
How is this Dlc Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 24286153707. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.